Company / Return on Assets (ROA)
AbbVie Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
3.1%
FY2025
5-year range
3.1% / 8.5%
FY2021-FY2025
Trend
-0.6%
vs FY2024
Sector context
#50 of 213
Health Care
What the data says
AbbVie's return on assets (roa) of 3.1% is higher than 77% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has declined for 3 consecutive years, from 8.5% in FY2022 to 3.1% in FY2025.
Based on SEC 10-K filings.
3.1% in FY2025 with a 5-year CAGR of +0.1%. Top quartile in the Health Care sector.
Declined from 3.6% to 3.1% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -5.4pp
- 5-Year Change
- +0.1pp
- 10-Year Change
- -
Sector benchmark
Top 23% in Health CareTop 23% of 213This company 3.1% Sector average -24.1%
▼
+113.1% above sector average
Key checks
Key Insights
- AbbVie's return on assets (roa) has declined for 3 consecutive years.
- In FY2025, return on assets (roa) decreased 0.6% year-over-year.
- Currently 27.2pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 3.1% | -0.6% |
| FY2024 | 3.2% | -12.2% |
| FY2023 | 3.6% | -57.7% |
| FY2022 | 8.5% | +8.2% |
| FY2021 | 7.9% | +156.7% |
| FY2020 | 3.1% | -65.3% |
| FY2019 | 8.8% | -7.7% |
| FY2018 | 9.6% | +27.7% |
| FY2017 | 7.5% | -16.8% |
| FY2016 | 9.0% | -7.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026